Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05858008

Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Julie Pendergast · Academic / Other
Sex
Female
Age
45 Years – 95 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the feasibility of implementing a time-restricted eating intervention in females with mild cognitive impairment. Targeted therapeutic interventions that improve cognitive impairment and delay onset of ADRD are particularly important for females, who have twice the lifetime risk of developing AD, compared to males.

Detailed description

This study will investigate the feasibility of implementing a time-restricted eating (TRE) intervention in females with mild cognitive impairment. Data will be collected for 10 weeks. Baseline food timing, activity/sleep, metabolic health (fasting labs and anthropometric measures), and cognitive testing will be collected in the first two weeks. Subjects will then be invited to enroll in a TRE intervention for 8 weeks. Subjects will be educated about the potential health benefits of TRE, and then each subject will self-select a 10-hr window and consume all daily calories during this time frame. Subjects will text the time of their first and last daily calories for the duration of the study. At the end of the 8-week TRE intervention, metabolic, anthropometric, activity/sleep, and cognitive measurements will be collected.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTime-restricted eatingSubjects will be educated about the health benefits of time-restricted eating. Each subject will self-select a 10-hour (10hr +/- 1 hr) window aligned with their active phase during which they will consume all daily calories. Subjects will text the time of their first and last daily calories for the duration of the study.

Timeline

Start date
2024-04-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2023-05-15
Last updated
2025-12-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05858008. Inclusion in this directory is not an endorsement.